Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride

EU orphan designation number: EU/3/09/685   
Active ingredient: N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride
Indication: Treatment of pancreatic cancer
Sponsor: Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/11/2009 Centralised Orphan - Designation EMEA/OD/069/09 (2009)8767 of 09/11/2009